Listen to the article
0:00
Les avantages vantés par les promoteurs des nouvelles techniques génomiques ressemblent fort à ceux déjà mis en avant il y a trente ans, lors de l’introduction des premiers OGM, observe, dans sa chronique, Stéphane Foucart, journaliste au « Monde ».
16 commentaires
Uranium names keep pushing higher—supply still tight into 2026.
Production mix shifting toward Sciences might help margins if metals stay firm.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Production mix shifting toward Sciences might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Production mix shifting toward Sciences might help margins if metals stay firm.
Good point. Watching costs and grades closely.